Biotika a.s. operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Biotika a.s. with three other
pharmaceutical manufacturers in Europe:
OptiBiotix Health PLC
of the United Kingdom
sales of £514,289.00 [US$667,043.12 ]
Bone Therapeutics SA
(1.00 million Euro [US$1.08 million]
based in Norway
(16.83 million Norwegian Kroner [US$1.81 million]
During the year ended December of 2018, sales at
Biotika a.s. were 1.38 million Slovak Koruny (US$1.49 million).
decrease of 20.9%
versus 2017, when the company's sales were 1.74 million Slovak Koruny.
Contributing to the drop in overall sales was the 97.4% decline
in Pharmacy, from 2.04 million Slovak Koruny to 53,913.00 Slovak Koruny.
There were also decreases in sales in
Services (down 13.2% to 1.32 million Slovak Koruny)
However, these declines were partially offset by the increase in sales of
Substances (up 20.6% to 24.63 million Slovak Koruny)